companydata.dkcompanydata.dk

Alfasigma Denmark ApS: Financial statements 2025

CVR: 42447242

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Alfasigma Denmark ApS (CVR 42447242) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 10,680,660 and a net result of DKK 505,448 compared with DKK 815,009 the year before. That is an increase of 12% compared with the year before. Equity in the 2025 report amounted to DKK 4,594,228. The solvency ratio was 39.4%. The company had 5 employees in the financial year.

Gross Profit
DKK 10,680,660
Profit/Loss
DKK 505,448
Equity
DKK 4,594,228
Total Assets
DKK 11,652,554
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-10.7 mio.505 t.4.6 mio.5
2024-9.5 mio.815 t.4.1 mio.4
2023-11.8 mio.1.4 mio.3.3 mio.6
2022-13.8 mio.1.4 mio.1.9 mio.6

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Alfasigma Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Line de Linde Henriksen joins Alfasigma Denmark ApS as directorJul 24, 2025

As of July 24, 2025, Line de Linde Henriksen is registered as director of Alfasigma Denmark ApS.

Alberto Avaltroni joins Alfasigma Denmark ApS as directorJul 24, 2025

As of July 24, 2025, Alberto Avaltroni is registered as director of Alfasigma Denmark ApS.

Marcel de Jong steps down as director of Alfasigma Denmark ApSJul 24, 2025

As of July 24, 2025, Marcel de Jong has stepped down as director of Alfasigma Denmark ApS.

Alfasigma Denmark ApS: The 2024 annual report is outJul 21, 2025

Alfasigma Denmark ApS has published its annual report for 2024. Gross profit came to DKK 9,532,078, and the net result was DKK 815,009.

About Alfasigma Denmark ApS

Alfasigma Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Galapagos Biopharma Denmark ApS. The management consists of Alberto Avaltroni, Alessio Battaglia and Line de Linde Henriksen. The company is owned by ALFASIGMA SpA. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 10,680,660 and a net result of DKK 505,448 compared with DKK 815,009 the year before. Equity in the 2025 report amounted to DKK 4,594,228.

Source: annual report 2025, Danish Business Authority

Other financial years